ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,252Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 2680

$1.57M Total Retail Price of All Prescriptions

Rank: 12 out of 2680

447 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 447 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 18,483 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

53% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
METOPROLOL SUCCINATE 693 681 1 11
ATORVASTATIN CALCIUM 637 618 2 10
AMLODIPINE BESYLATE 538 503 3 3
FUROSEMIDE 522 462 4 7
CRESTOR 510 495 5 15
NEXIUM 489 469 6 19
SYNTHROID 436 427 7 39
ZOLPIDEM TARTRATE 434 423 8 17
PLAVIX 429 421 9 41
DIOVAN 367 364 10 26
ISOSORBIDE MONONITRATE ER 352 344 11 57
JANUVIA 324 320 12 34
CLOPIDOGREL 312 309 13 30
SIMVASTATIN 283 272 14 1
LIDODERM 282 281 15 74
LIPITOR 267 255 16 78
METOPROLOL TARTRATE 263 261 17 8
DEXILANT 240 226 18 133
LOVAZA 232 220 19 47
METFORMIN HCL 228 216 20 6
DIOVAN HCT 213 213 21 54
CARVEDILOL 203 187 22 27
GLIMEPIRIDE 200 200 23 51
OMEPRAZOLE 196 189 24 2
ALCOHOL SWABS 193 190 25 181
JANUMET 191 190 26 83
DONEPEZIL HCL 188 188 27 28
ESCITALOPRAM OXALATE 174 174 28 82
RAMIPRIL 172 166 29 49
CREON 166 165 30 112
COUMADIN 162 162 31 154
LOSARTAN POTASSIUM 162 162 31 18
HYDRALAZINE HCL 158 146 33 99
ATENOLOL 157 154 34 14
POTASSIUM CHLORIDE 155 148 35 29
PANTOPRAZOLE SODIUM 154 150 36 44
DILTIAZEM 24HR CD 152 152 37 148
VOLTAREN 152 151 37 103
AZOR 149 149 39 188
EXFORGE 137 112 40 139
SPIRIVA 130 126 41 36
BYSTOLIC 122 113 42 104
RANEXA 121 113 43 173
AMLODIPINE BESYLATE-BENAZEPRIL 117 96 44 58
BENICAR 115 108 45 122
ENALAPRIL MALEATE 111 102 46 24
MECLIZINE HCL 109 108 47 105
TAMSULOSIN HCL 108 104 48 25
SERTRALINE HCL 106 94 49 23
SOLARAZE 99 96 50 172
LOSARTAN-HYDROCHLOROTHIAZIDE 98 98 51 46
ADVAIR DISKUS 97 84 52 32
WARFARIN SODIUM 95 95 53 12
GABAPENTIN 94 88 54 21
PAROXETINE HCL 90 90 55 62
TRAMADOL HCL 89 89 56 33
LYRICA 84 82 57 107
HYDROCHLOROTHIAZIDE 84 83 57 9
FAMOTIDINE 83 80 59 65
NITROGLYCERIN PATCH 82 80 60 171
RANITIDINE HCL 78 78 61 35
LISINOPRIL 77 77 62 5
DIGOXIN 77 77 62 59
ACETAMINOPHEN-CODEINE 74 62 S3 64 156
PRANDIN 74 74 64 191
PRAVASTATIN SODIUM 73 68 66 16
PROCTOZONE-HC 72 69 67 280
NIFEDIPINE ER 72 67 67 73
GLIPIZIDE XL 72 70 67 87
POLYETHYLENE GLYCOL 3350 71 67 70 55
NAMENDA 71 71 70 43
VENLAFAXINE HCL ER 71 71 70 111
ALLOPURINOL 71 58 70 42
TRIBENZOR 71 71 70 247
LUNESTA 70 69 75 297
LEVOTHYROXINE SODIUM 69 69 76 4
BENICAR HCT 68 65 77 125
DOXAZOSIN MESYLATE 67 65 78 127
SPIRONOLACTONE 67 47 78 86
LEXAPRO 66 66 80 218
AZITHROMYCIN 66 58 80 40
CLONIDINE 65 58 82 404
AMITIZA 63 63 83 190
SINGULAIR 62 62 84 64
ACTOS 60 60 85 98
MELOXICAM 60 52 85 50
DICYCLOMINE HCL 57 55 87 267
ALENDRONATE SODIUM 54 51 88 20
CIPROFLOXACIN HCL 54 53 88 85
CILOSTAZOL 54 42 88 263
ATELVIA 52 49 91 164
LIDOCAINE 52 52 91 186
CLOBETASOL PROPIONATE 51 49 93 231
TRILIPIX 50 45 94 151
ACTONEL 50 50 94 197
NYSTOP 50 46 94 183
PROAIR HFA 50 45 94 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.